News Release

This temporary tattoo could detect an unwanted drug in your drink

Peer-Reviewed Publication

American Chemical Society

This temporary tattoo could detect an unwanted drug in your drink

image: 

This tattoo-like sticker, which can be printed in a variety of designs, detects the presence of a drug often used to “spike” drinks — the letters turn red when exposed to it.

view more 

Credit: Adapted from ACS Sensors 2025, DOI: 10.1021/acssensors.4c03737

Temporary tattoos aren’t just for kids anymore — semi-permanent versions have become a favorite among adults who don’t want the commitment of the real thing. Now, researchers reporting in ACS Sensors have created their own temporary tattoo sticker that has a hidden, but possibly lifesaving, purpose: detecting the presence of one drug used to “spike” alcoholic beverages and facilitate sexual assault. The sticker responds within 1 second to even low concentrations of the drug γ-hydroxybutyrate (GHB).

Unfortunately, consuming a drink spiked with drugs including Rohypnol (commonly known as roofies) or GHB when drinking in a social setting is an ever-present danger — even among friends and acquaintances. These drugs are colorless and tasteless, inducing a stupor in the victim that’s similar to severe alcohol intoxication, which can lead people to being vulnerable to nonconsensual sexual contact or sexual assault. People can protect themselves by testing their drinks with specialized strips or cards that change color when exposed to these drugs. But current tests are often conspicuous or take minutes to report a result, introducing additional danger. So, Gyeong-Ji Kim, Jai Eun An, Kyong-Cheol Ko, Oh Seok Kwon and colleagues wanted to develop a rapid-acting test for GHB that’s worn on the skin using a tattoo-like sticker.

To create the stickers, the researchers placed a mold overtop a thin plastic film decorated with tattoo-like designs. Into the mold, they poured a gel mixture containing a chemical receptor that turns red when it detects GHB. Then they coated the back of the sticker with a diluted glue solution, so it could stick to skin.

The researchers tested the sticker’s ability to detect small amounts of GHB in a variety of beverages: whiskey, vodka, beer, soju (a Korean alcoholic beverage) and coffee. Within a single second, it detected the drug across a range of concentrations and below a level that would induce serious physiological symptoms: 0.01 micrograms of GHB in 1 milliliter of beverage. In practice, a wearer could dip a finger into a beverage, touch the drop to the sticker and see the result almost immediately. And the sticker displays the positive result for up to 30 days after detection, which could be important if it’s needed as a form of evidence of tampering. The researchers say that their sticker technology is inexpensive and easy to manufacture, and it could be commercially available soon.

The authors acknowledge funding from the National Research Foundation of Korea, the Korean National Research Council of Science & Technology, the Ministry of Food and Drug Safety, and the Nanomedical Devices Development Project of the National NanoFab Center.

The paper’s abstract will be available on July 23 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/10.1021/acssensors.4c03737    

###

The American Chemical Society (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.

Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.

Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.

Follow us: Facebook | LinkedIn | Instagram


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.